Intra-Cellular Therapies, Inc.

MetLife Investment Management, LLC

Report date

3/31/2025

Quarter

2025 Q1

Filed

5/14/2025

Shares

6,329

Value ($000)

835

Weight

0.0%

2018 Q3 - 2025 Q1 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q1	5/14/2025	835	0.0%	6,329	3/31/2025
2024 Q4	2/13/2025	530	0.0%	6,343	12/31/2024
2024 Q3	11/13/2024	475	0.0%	6,488	9/30/2024
2024 Q2	8/13/2024	453	0.0%	6,615	6/30/2024
2024 Q1	5/14/2024	3,322	0.0%	48,003	3/31/2024
2023 Q4	4/22/2024	3,536	0.0%	49,370	12/31/2023
2023 Q3	5/9/2024	2,572	0.0%	49,370	9/30/2023
2023 Q2	4/29/2024	3,126	0.0%	49,370	6/30/2023
2023 Q1	5/9/2024	2,592	0.0%	47,871	3/31/2023
2022 Q4	5/10/2024	2,578	0.0%	48,717	12/31/2022
2022 Q3	5/10/2024	2,267	0.0%	48,717	9/30/2022
2022 Q2	5/10/2024	2,716	0.0%	47,582	6/30/2022
2022 Q1	5/10/2024	2,601	0.0%	42,515	3/31/2022
2021 Q4	5/17/2024	1,275	0.0%	24,355	12/31/2021
2021 Q3	5/17/2024	987	0.0%	26,466	9/30/2021
2021 Q2	5/17/2024	1,080	0.0%	26,466	6/30/2021
2021 Q1	5/17/2024	898	0.0%	26,466	3/31/2021
2020 Q4	5/24/2024	842	0.0%	26,466	12/31/2020
2020 Q3	5/24/2024	679	0.0%	26,466	9/30/2020
2020 Q2	5/24/2024	679	0.0%	26,466	6/30/2020
2020 Q1	7/12/2023	358	0.0%	23,265	3/31/2020
2019 Q4	7/12/2023	673	0.0%	19,606	12/31/2019
2019 Q3	7/12/2023	146	0.0%	19,606	9/30/2019
2019 Q2	7/12/2023	254	0.0%	19,606	6/30/2019
2019 Q1	7/13/2023	239	0.0%	19,606	3/31/2019
2018 Q4	7/13/2023	223	0.0%	19,606	12/31/2018
2018 Q3	7/13/2023	425	0.0%	19,606	9/30/2018